We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Daiichi Sankyo Europe and Esperion Therapeutics announced the validation of the Marketing Authorisation Application (MAA) for bempedoic acid and the bempedoic acid / ezetimibe fixed dose combination tablet by the European Medicines Agency (EMA).
IH-TMS tool management system allows proactive monitoring of tool rotations and tooling inventory and maintenance. Software allows efficient, well-organised and in-depth monitoring of tablet production.
Johnson & Johnson Innovation announced 24 new companies have become residents of Johnson & Johnson Innovation, JLABS @ Toronto since its grand opening exactly a year ago.
Dutch pharmacist Emilia Sawicki defends that how some anticancer medicines can be formulated in such a way that patients take chemotherapy orally as a tablet, rather than as an intravenous infusion at the hospital.